Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €20.14 EUR
Change Today -1.27 / -5.95%
Volume 531.1K
FAGR On Other Exchanges
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

fagron (FAGR) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/24/15 - €43.92
52 Week Low
08/24/15 - €19.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for FAGRON (FAGR)

Related News

No related news articles were found.

fagron (FAGR) Related Businessweek News

No Related Businessweek News Found

fagron (FAGR) Details

Fagron NV, a scientific pharmaceutical research and development company, provides pharmaceutical compounding services worldwide. The company operates through two segments, Fagron and HL Technology. The Fagron segment provides compounding essentials, trademarks, and compounding services to pharmacies and hospital pharmacies. The HL Technology segment develops and produces precision components and orthopedic tools for dental and medical professionals. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV is headquartered in Waregem, Belgium.

2,143 Employees
Last Reported Date: 04/30/15

fagron (FAGR) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: €1.3M
Compensation as of Fiscal Year 2014.

fagron (FAGR) Key Developments

Fagron Reports Earnings Results for the First Six Months of 2015; Provides Earnings Guidance for 2015

Fagron reported earnings results for the first six months of 2015. For the period, the company reported net turnover of EUR 243,768,000 against EUR 209,149,000 a year ago. EBITDA before non-recurrent results was EUR 65,635,000 against EUR 55,670,000 a year ago. EBITDA was EUR 63,117,000 against EUR 53,154,000 a year ago. EBIT was EUR 51,440,000 against EUR 45,988,000 a year ago. Profit before taxes was EUR 37,135,000 against EUR 35,352,000 a year ago. Net profit was EUR 25,015,000 against EUR 24,488,000 a year ago. Recurrent net profit was EUR 26,072,000 or EUR 0.84 per share against EUR 26,575,000 or EUR 0.87 per share a year ago. Net profit per share from continued operations was EUR 0.80 against EUR 0.80 a year ago. REBITDA increased 17.9% to EUR 65.6 million. Based on current portfolio, the company expects turnover of at least EUR 500 million in 2015 with a REBITDA margin of 26%.

Fagron NV, H1 2015 Earnings Call, Aug 04, 2015

Fagron NV, H1 2015 Earnings Call, Aug 04, 2015

Fagron NV Proposes Dividend; Reports Consolidated and Standalone Turnover Results for the First Quarter of 2015; Provides Earnings Guidance for the Year 2015

Fagron NV proposed to the AGM to be held on May 11, 2015 a gross dividend of EUR 1.00 per share. This represents an increase of 39% compared to the dividend per share in 2014. The company reported consolidated and standalone turnover results for the first quarter of 2015. For the quarter, the consolidated turnover was EUR 117,800,000 compared to EUR 90,768,000 a year ago. For the quarter, the standalone turnover was EUR 114,952,000 compared to EUR 88,274,000 a year ago. The company provided earnings guidance for the year 2015. Based on the current portfolio the company expects in 2015 turnover of at least EUR 500 million with a REBITDA margin of 26%.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FAGR:BB €20.14 EUR -1.27

FAGR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lifco AB kr171.00 SEK +4.00
View Industry Companies

Industry Analysis


Industry Average

Valuation FAGR Industry Range
Price/Earnings 15.5x
Price/Sales 1.4x
Price/Book 4.0x
Price/Cash Flow 11.7x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FAGRON, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at